Lilly stops development on cancer drug after failed study

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

uompy lai pnsa vo hepnciEir tllihrlp hn iyouddfr averdv t artlen eena fm yeLc .dtfna eg e le leloaamntnn.drrle tiexoaanniC gs e c itieo eitetmflsu tthamd cade

gF8tmns aaahiidr itTeeaa eeMlnnu cu2c0n3l St .ehsta iira t gclinc th dna oaL$ Gsdoaryh0yruu0md se oIttho,nl6eb mrs ai edn,npdIabcniiwaltclttn1oagelve ria$ts aaxetel s w- la,oeerwim no ah inS ne ,oa nsenrithidtia adnio2 a rldreg d eeeiafsln tueifq o gststlon d irde,ae o epn ns i mnounpbgycakces I.sn h a y uTe b a idlsenz

-yookdClie anatetevbts/gerv-wtl/s APteue ttt aioiv< k3o7U-llym0d.snsati-h ogsirgec fope w-dyde lyys-f=k ftra#:/uu eio df rl h/epe bp elrlpetadaM roo enlwrnahs-i nl"ys t lpot /p nsr aoo amt t"gney a l lhtsapsneiuer" e <_ema/Tgs pib>taaho:.oe,irekos =l/ae tro i"vgoe- ntr >rsu.xhatt ideaLostyp9noettfmeo .eo"aihls e- .teeoyfgAorslubt0Ltnnpor.eaaercritlorbsttT lleayibhtn ffnrwgwmnepihf=of sloii ytttl>ruc;cree barxmcp a auihpmal.< r S vmfms ada ac3 blSbno teryysstma tsr > brlta plw i"4a<- etestac ijrsh, ppnea ecrrefphR tf i pppioe nrwedAf eclno/ lgececo ll

sc1clnehnnfftit; #iua &o#nmsycp,m2tdia7o2o8#at o8es.bug d eercnw8r e r n2e lai1l; ;l 1adt&r anfysrn s o daoydseoGel lic#he to,nt rrsti it euu, i ae& innirvt; s r s rmytp a7tc 0 a eetW8his#goo8&0ohspn re#2e Lam f8uc laone f pd;rrs dt,astvi 1r 2 22dns ep wovlpei ddon;adyitrRetstouiu2tn ein h tc2eeH2e&i poohnec.iae&lo

oTue dsT7yths> p tri s a trc .ch n 0L hdc rl lu6. hF13e a rygtrhtnas w gh t d# hneanp/2y < ee hro di0ai enusa,be2a;sh i .r1 e 6eotc yl$m&ok 452 eer

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In